STOCK TITAN

[6-K] Haleon plc Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Haleon plc reports it purchased 4,314,000 ordinary shares of £0.01 each under the second tranche of its buyback programme announced 31 July 2025. The company intends to hold the purchased shares as treasury shares. After settlement the company's registered share capital is 8,952,353,648 ordinary shares, of which 18,887,545 are treasury shares, leaving 8,933,466,103 ordinary shares with voting rights. Shareholders may use the voting-rights figure to determine notification obligations under the FCA Disclosure Guidance and Transparency Rules. A full breakdown of individual trades is available via the provided RNS link and on the company website.

Haleon plc riferisce di aver acquistato 4.314.000 azioni ordinarie da £0,01 ciascuna nell'ambito della seconda tranche del programma di riacquisto annunciato il 31 luglio 2025. la società intende detenere le azioni acquisite come azioni tesoreria. Dopo la regolazione, il capitale sociale registrato della società è 8.952.353.648 azioni ordinarie, di cui 18.887.545 sono azioni tesoreria, lasciando 8.933.466.103 azioni ordinarie con diritto di voto. Gli azionisti possono utilizzare la cifra relativa ai diritti di voto per determinare le obbligazioni di segnalazione secondo le FCA Disclosure Guidance and Transparency Rules. Una ripartizione completa delle singole operazioni è disponibile tramite il link RNS fornito e sul sito della società.

Haleon plc informa que compró 4.314.000 acciones ordinarias de £0,01 cada una, dentro la segunda tranche de su programa de recompra anunciado el 31 de julio de 2025. la compañía tiene la intención de mantener las acciones adquiridas como acciones en tesorería. Tras la liquidación, el capital social registrado de la empresa es 8.952.353.648 acciones ordinarias, de las cuales 18.887.545 son acciones en tesorería, quedando 8.933.466.103 acciones ordinarias con derecho a voto. Los accionistas pueden usar la cifra de derechos de voto para determinar las obligaciones de notificación conforme a las FCA Disclosure Guidance and Transparency Rules. Un desglose completo de las operaciones individuales está disponible a través del enlace de RNS proporcionado y en la web de la empresa.

Haleon plc은 2025년 7월 31일에 발표된 두 번째 차수 대주주 매입 프로그램에 따라 4,314,000주(주당 £0.01)의 보통주를 매입했다고 발표합니다. 회사는 매입한 주식을 자사주로 보유할 예정입니다. 결제 후 회사의 등록된 자본은 8,952,353,648주의 보통주로, 그 중 18,887,545주가 자사주이며, 의결권이 부여된 보통주는 8,933,466,103주로 남습니다. 주주들은 의결권 수치를 이용해 FCA의 공시 지침 및 투명성 규칙에 따른 보고 의무를 판단할 수 있습니다. 개별 거래의 전체 내역은 제공된 RNS 링크와 회사 웹사이트에서 확인할 수 있습니다.

Haleon plc indique avoir acheté 4 314 000 actions ordinaires de £0,01 chacune dans le cadre de la deuxième tranche de son programme de rachat annoncé le 31 juillet 2025. La société a l'intention de détenir les actions achetées en tant qu'actions propres. Après la compensation, le capital social enregistré de la société s’élève à 8 952 353 648 actions ordinaires, dont 18 887 545 sont des actions propres, laissant 8 933 466 103 actions ordinaires avec droit de vote. Les actionnaires peuvent utiliser le chiffre relatif au droit de vote pour déterminer les obligations de notification conformément aux règles de divulgation et de transparence de la FCA. Une ventilation complète des transactions individuelles est disponible via le lien RNS fourni et sur le site de la société.

Haleon plc meldet, dass es im Rahmen der zweiten Tranche seines am 31. Juli 2025 angekündigten Rückkaufprogramms 4.314.000 Stammaktien mit jeweils £0,01 erworben hat. Das Unternehmen beabsichtigt, die erworbenen Aktien als Treasury Shares zu halten. Nach Abwicklung beträgt das eingetragene Grundkapital der Gesellschaft 8.952.353.648 Stammaktien, wovon 18.887.545 Treasury Shares sind, was 8.933.466.103 Stammaktien mit Stimmrechten übrig lässt. Aktionäre können die Stimmrechtszahl verwenden, um Verpflichtungen zur Offenlegung gemäß den FCA Disclosure Guidance and Transparency Rules zu bestimmen. Eine vollständige Aufschlüsselung der einzelnen Trades ist über den bereitgestellten RNS-Link und auf der Unternehmenswebseite verfügbar.

Haleon plc تفيد بأنها اشترت 4,314,000 سهمًا عاديًا من فئة £0.01 لكل سهم، وذلك ضمن الشريحة الثانية من برنامج إعادة الشراء المعلن عنه في 31 يوليو 2025. تعتزم الشركة الاحتفاظ بالأسهم المشتراة كأسهم خزينة. بعد التسوية، يبلغ رأس المال المسجل للشركة 8,952,353,648 سهماً عادياً، من بينها 18,887,545 سهماً خزينة، مما يترك 8,933,466,103 أسهم عادية ذات حقوق تصويت. يمكن للمساهمين استخدام رقم حقوق التصويت لتحديد الالتزامات بالإبلاغ وفقاً لإرشادات FCADisclosure Guidance and Transparency Rules. تتوفر تفصيلات كاملة للصفقات الفردية عبر رابط RNS المقدم وعلى موقع الشركة.

Haleon plc 报告称在其于 2025 年 7 月 31 日宣布的回购计划第二阶段中,以每股面值 £0.01 的价格购买了 4,314,000 股普通股。公司打算将所购股票作为库藏股持有。结算后,公司登记的普通股资本为 8,952,353,648 股,其中 18,887,545 股为库藏股,留有 8,933,466,103 股具有表决权。股东可据此表决权数确定须遵循的 FCA 披露与透明度规则下的通知义务。单笔交易的完整明细可通过所提供的 RNS 链接及公司官网获得。

Positive
  • Execution of buyback: Completed purchase of 4,314,000 shares under the announced programme
  • Treasury holding: Shares will be held as treasury, preserving future flexibility for company use
  • Regulatory transparency: Trade-level breakdown published in accordance with Market Abuse Regulation
Negative
  • None.

Insights

TL;DR: Share repurchase modestly reduces outstanding voting stock and signals capital return to shareholders.

The announced purchase of 4,314,000 shares, held as treasury, reduces the number of shares with voting rights to 8,933,466,103. For investors this is a straightforward execution of the second tranche of the buyback program and indicates management is deploying capital to return value. The disclosure includes a trade-level breakdown via RNS in line with market-abuse transparency rules, enabling verification of execution prices and volumes. No earnings or debt information is provided to assess funding or broader financial impact.

TL;DR: Procedural disclosure meets regulatory transparency; treasury holding affects voting base.

The filing clearly states intent to hold purchased shares as treasury, which preserves flexibility for future use such as employee schemes or cancellations. The updated counts for registered capital, treasury shares, and voting shares provide necessary inputs for shareholder notification thresholds under FCA rules. The company references a public breakdown of individual trades, satisfying Market Abuse Regulation reporting requirements. The report contains no information on buyback funding source or impact on capital allocation beyond the share counts.

Haleon plc riferisce di aver acquistato 4.314.000 azioni ordinarie da £0,01 ciascuna nell'ambito della seconda tranche del programma di riacquisto annunciato il 31 luglio 2025. la società intende detenere le azioni acquisite come azioni tesoreria. Dopo la regolazione, il capitale sociale registrato della società è 8.952.353.648 azioni ordinarie, di cui 18.887.545 sono azioni tesoreria, lasciando 8.933.466.103 azioni ordinarie con diritto di voto. Gli azionisti possono utilizzare la cifra relativa ai diritti di voto per determinare le obbligazioni di segnalazione secondo le FCA Disclosure Guidance and Transparency Rules. Una ripartizione completa delle singole operazioni è disponibile tramite il link RNS fornito e sul sito della società.

Haleon plc informa que compró 4.314.000 acciones ordinarias de £0,01 cada una, dentro la segunda tranche de su programa de recompra anunciado el 31 de julio de 2025. la compañía tiene la intención de mantener las acciones adquiridas como acciones en tesorería. Tras la liquidación, el capital social registrado de la empresa es 8.952.353.648 acciones ordinarias, de las cuales 18.887.545 son acciones en tesorería, quedando 8.933.466.103 acciones ordinarias con derecho a voto. Los accionistas pueden usar la cifra de derechos de voto para determinar las obligaciones de notificación conforme a las FCA Disclosure Guidance and Transparency Rules. Un desglose completo de las operaciones individuales está disponible a través del enlace de RNS proporcionado y en la web de la empresa.

Haleon plc은 2025년 7월 31일에 발표된 두 번째 차수 대주주 매입 프로그램에 따라 4,314,000주(주당 £0.01)의 보통주를 매입했다고 발표합니다. 회사는 매입한 주식을 자사주로 보유할 예정입니다. 결제 후 회사의 등록된 자본은 8,952,353,648주의 보통주로, 그 중 18,887,545주가 자사주이며, 의결권이 부여된 보통주는 8,933,466,103주로 남습니다. 주주들은 의결권 수치를 이용해 FCA의 공시 지침 및 투명성 규칙에 따른 보고 의무를 판단할 수 있습니다. 개별 거래의 전체 내역은 제공된 RNS 링크와 회사 웹사이트에서 확인할 수 있습니다.

Haleon plc indique avoir acheté 4 314 000 actions ordinaires de £0,01 chacune dans le cadre de la deuxième tranche de son programme de rachat annoncé le 31 juillet 2025. La société a l'intention de détenir les actions achetées en tant qu'actions propres. Après la compensation, le capital social enregistré de la société s’élève à 8 952 353 648 actions ordinaires, dont 18 887 545 sont des actions propres, laissant 8 933 466 103 actions ordinaires avec droit de vote. Les actionnaires peuvent utiliser le chiffre relatif au droit de vote pour déterminer les obligations de notification conformément aux règles de divulgation et de transparence de la FCA. Une ventilation complète des transactions individuelles est disponible via le lien RNS fourni et sur le site de la société.

Haleon plc meldet, dass es im Rahmen der zweiten Tranche seines am 31. Juli 2025 angekündigten Rückkaufprogramms 4.314.000 Stammaktien mit jeweils £0,01 erworben hat. Das Unternehmen beabsichtigt, die erworbenen Aktien als Treasury Shares zu halten. Nach Abwicklung beträgt das eingetragene Grundkapital der Gesellschaft 8.952.353.648 Stammaktien, wovon 18.887.545 Treasury Shares sind, was 8.933.466.103 Stammaktien mit Stimmrechten übrig lässt. Aktionäre können die Stimmrechtszahl verwenden, um Verpflichtungen zur Offenlegung gemäß den FCA Disclosure Guidance and Transparency Rules zu bestimmen. Eine vollständige Aufschlüsselung der einzelnen Trades ist über den bereitgestellten RNS-Link und auf der Unternehmenswebseite verfügbar.

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of September 2025
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
19 September 2025 - “Transaction in Own Shares”
 
 
99.1
 
 
Haleon plc: Transaction in own shares
 
19 September 2025: Haleon plc (the "Company" or "Haleon") today announces the purchase of 4,314,000 ordinary shares of £0.01 each in the Company (the "Shares") under the second tranche of its share buyback programme announced on 31 July 2025.
 
 
London Stock Exchange
CBOE (UK)/BXE
CBOE (UK)/CXE
Date of purchase:
18 September 2025
18 September 2025
18 September 2025
Number of Shares purchased:
3,374,000
940,000
-
Highest price paid per Share (p):
344.4500
342.0000
-
Lowest price paid per Share (p):
340.2000
340.2000
-
Volume weighted average price paid per Share (p):
341.8544
341.2133
-
 
The Company intends to hold the purchased shares as treasury shares.
 
Following the settlement of the above, the Company's registered share capital is 8,952,353,648 ordinary shares of £0.01 each, of which 18,887,545 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,933,466,103 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
 
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:
 
http://www.rns-pdf.londonstockexchange.com/rns/9590Z_1-2025-9-18.pdf
 
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
 
This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.
 
Enquiries
 
 
Investors
Media
 
Jo Russell  
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel     
+44 7552 484646
Victoria Durman
+44 7894 505730
Email: investor-relations@haleon.com
Email: corporate.media@haleon.com
 
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
 
For more information, please visit www.haleon.com
 
 
 
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: September 19, 2025
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

FAQ

How many shares did Haleon (HLNCF) buy under the second tranche?

The company purchased 4,314,000 ordinary shares of £0.01 each.

Will Haleon hold the repurchased shares or cancel them?

Haleon intends to hold the purchased shares as treasury shares.

What is the number of Haleon shares with voting rights after this buyback?

After settlement the number of ordinary shares with voting rights is 8,933,466,103.

Where can I find the detailed breakdown of the individual trades?

A full breakdown is available via the RNS link: http://www.rns-pdf.londonstockexchange.com/rns/9590Z_1-2025-9-18.pdf and on the company's investor website.

Does this filing disclose how the buyback was funded?

The filing does not provide any information on the funding source for the buyback.
HALEON PLC

OTC:HLNCF

HLNCF Rankings

HLNCF Latest SEC Filings

HLNCF Stock Data

8.93B